Traws Pharma, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
TRAW on Nasdaq
Industry
Pharmaceutical Preparations
Location
12 Penns Trail, Newtown, PA

There are no Buy or Sell transactions made by insiders since 11/21/2023

Traws Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viriom, Inc. 10%+ Owner $1.48M Apr 3, 2024
Tpav, Llc 10%+ Owner $1.1M Apr 1, 2024
Orbimed Advisors Llc 10%+ Owner $283K Sep 16, 2024
Werner Cautreels Chief Executive Officer, Director $180K Apr 1, 2024
Steven M. Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF, Director $98.3K Mar 13, 2024
Charles David Pauza Chief Science Officer Virology $87.8K Apr 1, 2024
Robert Redfield Acting Chief Medical Officer $87.8K Apr 1, 2024
Nikolay Savchuk Chief Operating Officer, Director $63.1K Apr 1, 2024
Iain D. Dukes Executive Chairman, Director $63.1K Apr 1, 2024
Abraham N. Oler SVP Corp Dev & Gen Counsel $36.8K Feb 7, 2022
Mark Guerin Cfo $23.4K Jun 10, 2024
Mark S. MD Gelder Chief Medical Officer $13.8K Mar 13, 2023
Peter Atadja Director Aug 10, 2023
Jerome Groopman Director Aug 10, 2023
Victor M. Moyo Chief Medical Officer Oct 2, 2023
Viren Mehta Director Aug 10, 2023
James J. Marino Director Aug 10, 2023
Jack E. Stover Director Aug 10, 2023
Mary Teresa Shoemaker Director Aug 10, 2023
Trafford Clarke Director Aug 10, 2023
Luba Greenwood Director Sep 16, 2024

Recent Insider Transactions by Companies or Individuals for Traws Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.